UMB Financial Form 144 Discloses Insider Sale and Recent Trust Dispositions

Rhea-AI Filing Summary

Form 144 notice for UMB Financial Corporation (UMBFP) discloses a proposed sale of 3,500 common shares via Merrill with an aggregate market value of $438,752.00, planned for 09/09/2025 on NASDAQ. The shares were acquired on 01/27/2025 as restricted stock that vested from UMB Financial, with payment dated the same day. The filing lists the issuer's outstanding shares as 48,798,443. The form also itemizes multiple recent trust sales of company common stock during August and September 2025 totaling several transactions (largest single sale listed: 15,523 shares on 08/13/2025 for $1,805,742.47). The filer certifies no undisclosed material adverse information and includes the standard signature/attestation language.

Positive

• Regulatory compliance: The filer provided required Rule 144 details including acquisition date, nature of acquisition, broker, planned sale date, and attestation of no undisclosed material information.
• Transparency on prior sales: The filing lists multiple recent trust sales with dates and gross proceeds, offering clear historical context for recent insider-related dispositions.

Negative

• Insider-related selling activity: Multiple sales by related trusts occurred in August–September 2025, including a sale of 15,523 shares on 08/13/2025 for $1,805,742.47, which could be interpreted as increased insider liquidity.
• Planned sale: A proposed sale of 3,500 vested restricted shares is scheduled for 09/09/2025, representing insider-originated supply into the market.

Insights

Securities Analyst

TL;DR: Insiders and related trusts disclosed ongoing sales; this is routine compliance, not a direct earnings signal.

The filing shows a beneficiary-level proposed sale of 3,500 restricted shares that vested on 01/27/2025 and multiple recent trust dispositions during August–September 2025. The proposed sale is small relative to the reported outstanding share count of 48,798,443, and the filing adheres to Rule 144 disclosure requirements. For investors, such filings primarily indicate liquidity events by insiders or related trusts rather than operating performance. Monitor aggregate insider selling if disclosures show sustained or larger volumes over time.

Corporate Governance Expert

TL;DR: The Form 144 appears complete for Rule 144 purposes and includes customary attestations; no governance red flags in this notice alone.

The notice identifies the acquisition source (restricted stock vesting) and timing, the broker, sale date, and prior trust sales, and contains the required attestation regarding material nonpublic information. The document does not reveal any executive departures, related-party transactions beyond trust dispositions, or compliance failures. Governance implications are limited to transparency around insider liquidity; any broader governance assessment requires additional disclosures not present here.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill 8890 Lyra Dr 5th Flr Columbus OH 43240	3500	438752.00	48798443	09/09/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/27/2025	Restricted stock vest	UMB Financial			3500	01/27/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
RC Kemper Chariable Trust & Foundation 1010 Grand Blvd Kansas City MO 64106	Common	09/02/2025	1875	226029.51
R C Kemper Jr Charitable Trust & Foundation 1010 Grand Blvd Kansas City MO 64106	Common	09/02/2025	3825	461100.16
Bebe & Grosby Kemper Foundation 1010 Grand Blvd Kansas City MO 64106	Common	09/02/2025	864	104154.40
R C Kemper Marital Trust 1010 Grand Blvd, Kansas City MO 64106	Common	08/13/2025	15523	1805742.47
Bebe & Grosby Kemper Foundation 1010 Grand Blvd Kansas City MO 64106	Common	08/27/2025	288	35446.12
RC Kemper Chariable Trust & Foundation 1010 Grand Blvd Kansas City MO 64106	Common	08/27/2025	625	76923.00
R C Kemper Jr Charitable Trust & Foundation 1010 Grand Blvd Kansas City MO 64106	Common	08/27/2025	1275	156922.92

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for UMBFP disclose?

It discloses a proposed sale of 3,500 common shares acquired as restricted stock on 01/27/2025, to be sold on 09/09/2025 via Merrill on NASDAQ, with aggregate market value $438,752.00.

Who originally acquired the shares being sold according to the filing?

UMB Financial is listed as the source of the restricted stock that vested on 01/27/2025 for the 3,500 shares.

Are there recent insider or trust sales disclosed in this filing?

Yes. The filing lists multiple trust sales in Aug–Sep 2025, including 15,523 shares sold on 08/13/2025 for $1,805,742.47 and other sales on 08/27/2025 and 09/02/2025.

How many shares outstanding does the filing report for UMBFP?

The filing reports 48,798,443 shares outstanding.

Does the filer assert possession of material nonpublic information?

No. The signature section contains the representation that the person does not know any material adverse information not publicly disclosed.